Daniel Krappmann Molecular Targets and Therapies Center (MTTC) Munich
2 protocols

Thomas O'Neill Helmholtz Zentrum Munich
1 protocol

Andreas Gewies
  • Research Associate, Helmholtz Zentrum Munich
Research focus
  • Signaltransduction from antigen receptors to the transcription factor NF-kappaB
  • 1 Author merit


University, TU Berlin, 1996

Lab information

Daniel Krappmann's Lab

1 Protocol published
Optimized CRISPR-Cas9-based Strategy for Complex Gene Targeting in Murine Embryonic Stem Cells for Germline Transmission
Authors:  Thomas J. O'Neill, Daniel Krappmann and Andreas Gewies, date: 05/20/2022, view: 817, Q&A: 0

Although CRISPR-Cas9 genome editing can be performed directly in single-cell mouse zygotes, the targeting efficiency for more complex modifications such as the insertion of two loxP sites, multiple mutations in cis, or the precise insertion or

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.